Back
Kandi Technologies Group Vs. Blueprint Medicines Industry Stock Comparison
Sell
44
KNDI
Kandi Technologies Group
Last Price:
$1.09
Seasonality Move:
5.92%
Sell
48
BPMC
Blueprint Medicines
Last Price:
$128.70
Seasonality Move:
7.99%
Sell
44
Kandi Technologies Group (KNDI)
is a Sell
Is Kandi Technologies Group a Buy, Sell or Hold?
-
The current Kandi Technologies Group [KNDI] share price is $1.13. The Score for KNDI is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
-
KNDI is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
48
Blueprint Medicines (BPMC)
is a Sell
Is Blueprint Medicines a Buy, Sell or Hold?
-
The current Blueprint Medicines [BPMC] share price is $128.40. The Score for BPMC is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
-
BPMC is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
KNDI Stock Price Chart
What is Kandi Technologies Group's stock price today?
-
The Kandi Technologies Group share price today is $1.13Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and KNDI is experiencing slight selling pressure.
BPMC Stock Price Chart
What is Blueprint Medicines's stock price today?
-
The Blueprint Medicines share price today is $128.40Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BPMC is experiencing buying pressure, which is a positive indicator for future bullish movement.
KNDI Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.01 | Sell |
Relative Strength Index (14 RSI): | 51.23 | Buy |
Chaikin Money Flow: | 23991 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | ( - ) | Buy |
Bollinger Bands (100): | ( - ) | Buy |
BPMC Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 4.37 | Buy |
Relative Strength Index (14 RSI): | 74.7 | Buy |
Chaikin Money Flow: | 1263634 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (121.79 - 132.29) | Buy |
Bollinger Bands (100): | (84.54 - 117.4) | Buy |
KNDI Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.11 | Buy |
20-day SMA: | 1.11 | Buy |
50-day SMA: | 1.15 | Sell |
200-day SMA: | 1.28 | Sell |
8-day EMA: | 1.11 | Buy |
20-day EMA: | 1.12 | Buy |
50-day EMA: | 1.15 | Sell |
200-day EMA: | 1.36 | Sell |
BPMC Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 128.25 | Buy |
20-day SMA: | 128.17 | Buy |
50-day SMA: | 112.43 | Buy |
200-day SMA: | 97.81 | Buy |
8-day EMA: | 128.21 | Buy |
20-day EMA: | 125.53 | Buy |
50-day EMA: | 115.59 | Buy |
200-day EMA: | 101.04 | Buy |
Kandi Technologies Group Earnings Growth & KNDI Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.10 per share, and a decrease next year of $0.00 per share.
Blueprint Medicines Earnings Growth & BPMC Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.67 per share, an increase next quarter of $0.33 per share, an increase this year of $0.60 per share, and an increase next year of $1.50 per share.
Kandi Technologies Group Technical Analysis
Jun 23 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 30 | Jul 1 | Jul 2 | Jul 3 | Jul 7 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | Jul | |||||||||
23 | 24 | 25 | 26 | 27 | 30 | 01 | 02 | 03 | 07 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Blueprint Medicines Technical Analysis
Jun 23 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 30 | Jul 1 | Jul 2 | Jul 3 | Jul 7 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | Jul | |||||||||
23 | 24 | 25 | 26 | 27 | 30 | 01 | 02 | 03 | 07 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |